High Velocity Therapy® was an important part of Emergency Medicine and Critical Care Physicians and Clinicians respiratory support armamentarium during the COVID pandemic. This resulted in a great increase in the awareness and use of the therapy for acute hypoxemic respiratory distress.
Vapotherm’s High Velocity Therapy Precision Flow® Hi-VNI and HVT® 2.0 product platforms administer a mask-free form of non-invasive respiratory support to treat undifferentiated respiratory distress, including hypercapnia, hypoxemia and dyspnea. It blends the comfort of heated high flow nasal cannula and the respiratory support of NIV, for spontaneously breathing patients. In the following Roundtable discussion, Emergency Medicine and Critical Care Physicians experts in respiratory therapy explain different applications for the system for increased work of breathing in both lung and non-lung pathology patients.